(19)
(11)
EP 1 140 143 A2
(12)
(88)
Date of publication A3:
14.09.2000
(43)
Date of publication:
10.10.2001
Bulletin 2001/41
(21)
Application number:
99965894.1
(22)
Date of filing:
16.12.1999
(51)
International Patent Classification (IPC)
7
:
A61K
38/21
,
A61K
31/7056
,
A61P
31/14
(86)
International application number:
PCT/US9927/935
(87)
International publication number:
WO 0037/110
(
29.06.2000
Gazette 2000/26)
(84)
Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI
(30)
Priority:
18.12.1998
US 215876
(71)
Applicant:
SCHERING CORPORATION
KenilworthNew Jersey 07033 (US)
(72)
Inventors:
GLUE, Paul, W.
Flemington, NJ 08822 (US)
ALBRECHT, Janice, K.
Winter Park, FL 32789 (US)
(74)
Representative:
Ritter, Stephen David et al
Mathys & Squire100 Gray's Inn Road
London WC1X 8AL
London WC1X 8AL (GB)
(54)
RIBAVIRIN-PEGYLATED INTERFERON ALFA INDUCTION HCV COMBINATION THERAPY